WANDA BEARING
920002
HENDERA
831152
LINGOOD
833284
4
WUHAN LAND
830779
5
TECHVISION
832876
US Stock MarketDetailed Quotes
KAPA Kairos Pharma
- 1.240
- +0.100+8.77%
Close Feb 26 16:00 ET
- 1.160
- -0.080-6.45%
Pre 08:34 ET
16.99MMarket Cap-5.90P/E (TTM)
1.400High1.140Low198.63KVolume1.160Open1.140Pre Close242.28KTurnover12.82%Turnover RatioLossP/E (Static)13.70MShares4.00052wk High5.10P/B1.92MFloat Cap0.85152wk Low--Dividend TTM1.55MShs Float4.000Historical High--Div YieldTTM22.81%Amplitude0.851Historical Low1.219Avg Price1Lot Size
About Kairos Pharma Company
Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of novel and transformative drug therapies to treat cancer. It focuses on the research and development of immunotherapies for oncology. The company was founded by John S. Yu on June 17, 2013 and is headquartered in Los Angeles, CA.
Company Profile
SymbolKAPA
Company NameKairos Pharma
Listing DateSep 16, 2024
Founded2013
CEODr. John S. Yu,M.D.
MarketAMEX
Employees3
Fiscal Year Ends12-31
Address2355 Westwood Boulevard,Suite 139
CityLos Angeles
ProvinceCalifornia
CountryUnited States of America
Zip Code90064
Phone1-310-948-2356
Websitehttp://kairospharma.com
Company Executives
- Name
- Position
- Salary
- Dr. John S. Yu,M.D.
- Chairman of the Board and Chief Executive Officer
- --
- Neil Bhowmick
- Chief Scientific Officer
- --
- Doug Samuelson
- Chief Financial Officer
- --
- Ramachandran Murali, PhD
- Vice President of Research and Development
- --
- Dr. Rahul Singhvi, Sc.D.
- Director
- --
- Hyun W. Bae, M.D.
- Independent Director
- --
- Dr. Hansoo Michael Keyoung, M.D.,PhD
- Independent Director
- --
Trending Stocks
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve
Moo Earnings
Feb 2 12:39
AMZN earnings preview: Grab rewards by guessing the opening price!